Items without sitelinks

From determinar.ia.br - Determine suas informações

Showing below up to 50 results in range #21,251 to #21,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Renal mass (Q91559)
  2. Ureter filling defect (Q91558)
  3. Fibroepithelial neoplasms- ICD-O3 view (Q91557)
  4. Malignant neoplasms of respiratory or intrathoracic organs (Q91556)
  5. Bladder filling defect (Q91555)
  6. Kidney filling defect (Q91554)
  7. Parkinsonism in hereditary spastic paraplegia (Q91553)
  8. Gynandroblastoma of ovary (Q91552)
  9. Parkinsonism due to spinocerebellar ataxias (Q91551)
  10. Screening for intestinal protozoal disease (Q91550)
  11. Parkinsonism in Wilson's disease (Q91549)
  12. Ovarian malignant Sertoli-Leydig cell tumour (Q91548)
  13. Vitiligo of upper eyelid or periocular area (Q91547)
  14. Exposure to excessive cold of human origin, undetermined intent (Q91546)
  15. Cutaneous microvascular occlusion by emboli (Q91545)
  16. Cutaneous microvascular disturbances due to dysproteinaemia (Q91544)
  17. Parkinsonism due to Neurodegeneration with brain iron accumulation NBIA (Q91543)
  18. Cutaneous microvascular disturbances due to vascular coagulopathies (Q91542)
  19. Exposure to excessive cold of natural origin, undetermined intent (Q91541)
  20. Glomerular disorders in plasmodium malariae malaria (Q91540)
  21. Drug-induced osteonecrosis, humerus (Q91539)
  22. Parkinsonism in Huntington disease (Q91538)
  23. X-linked dystonia parkinsonism (Q91537)
  24. Vitiligo of lower eyelid or periocular area (Q91536)
  25. Cutaneous microvascular occlusion by platelet plugs (Q91535)
  26. Theca steroid-producing cell malignant tumour, not further specified (Q91534)
  27. Cutaneous microvascular occlusion due to systemic coagulopathies (Q91533)
  28. Certain specified motility disorder (Q91532)
  29. Intentional self-harm by exposure to or harmful effects of other nonsteroidal anti-inflammatory drugs (Q91531)
  30. Intentional self-harm by exposure to or harmful effects of paracetamol (Q91530)
  31. Adult Krabbe disease (Q91529)
  32. Moyamoya disease (Q91528)
  33. Infantile Krabbe disease (Q91527)
  34. Secondary moyamoya (Q91526)
  35. Late-infantile or juvenile Krabbe disease (Q91525)
  36. Intentional self-harm by exposure to or harmful effects of 4-Aminophenol derivatives (Q91524)
  37. Cholera screening (Q91523)
  38. Intentional self-harm by exposure to or harmful effects of ibuprofen (Q91522)
  39. Intentional self-harm by exposure to or harmful effects of indomethacin (Q91521)
  40. Screening for intestinal helminthiasis (Q91520)
  41. Intentional self-harm by exposure to or harmful effects of other propionic acid derivatives (Q91519)
  42. Intentional self-harm by exposure to or harmful effects of aspirin (Q91518)
  43. Intentional self-harm by exposure to or harmful effects of other salicylates (Q91517)
  44. Unintentionally struck, kicked, or bumped by land mammal (Q91516)
  45. Intentional self-harm by exposure to or harmful effects of antirheumatics, not elsewhere classified (Q91515)
  46. Intentional self-harm by exposure to or harmful effects of pyrazolone derivatives (Q91514)
  47. Hydrocephalus due to congenital toxoplasmosis (Q91513)
  48. Entanglement of cords of twins in monoamniotic sac (Q91512)
  49. Congenital toxoplasma encephalitis (Q91511)
  50. General or plastic surgery devices associated with adverse incidents, liposuction equipment (Q91510)

View ( | ) (20 | 50 | 100 | 250 | 500)